Real-World Effectiveness of Risankizumab for Moderate-to-Severe Plaque Psoriasis by Sub-populations: Interim Analysis from VALUE at 37 Months

Diamant Thaçi, Franca Wiemers, Charles W. Lynde, Mamitaro Ohtsuki, Luca Bianchi, Anne-Claire Fougerousse, Francisco Javier Garcia-Latasa de Aranibar, Simina Stefanescu, Spyridon Gkalpakiotis, Paul-Gunther Sator, Julia-Tatjana Maul, Andrea Szegedi, Paula C. Luna, Lynda Spelman, Simone Rubant, Tshepiso Madihlaba, Hongwei Wang, Doug Ashley, Kim A. Papp

Open source

DOI: 10.1007/s13555-026-01954-0
Published: 2026-11-06
Container: Dermatology and Therapy
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01954-0,
  title = {Real-World Effectiveness of Risankizumab for Moderate-to-Severe Plaque Psoriasis by Sub-populations: Interim Analysis from VALUE at 37 Months},
  author = {Diamant Thaçi and Franca Wiemers and Charles W. Lynde and Mamitaro Ohtsuki and Luca Bianchi and Anne-Claire Fougerousse and Francisco Javier Garcia-Latasa de Aranibar and Simina Stefanescu and Spyridon Gkalpakiotis and Paul-Gunther Sator and Julia-Tatjana Maul and Andrea Szegedi and Paula C. Luna and Lynda Spelman and Simone Rubant and Tshepiso Madihlaba and Hongwei Wang and Doug Ashley and Kim A. Papp},
  year = {2026},
  journal = {Dermatology and Therapy},
  doi = {10.1007/s13555-026-01954-0},
  url = {https://doi.org/10.1007/s13555-026-01954-0}
}

RIS

TY  - JOUR
TI  - Real-World Effectiveness of Risankizumab for Moderate-to-Severe Plaque Psoriasis by Sub-populations: Interim Analysis from VALUE at 37 Months
AU  - Diamant Thaçi
AU  - Franca Wiemers
AU  - Charles W. Lynde
AU  - Mamitaro Ohtsuki
AU  - Luca Bianchi
AU  - Anne-Claire Fougerousse
AU  - Francisco Javier Garcia-Latasa de Aranibar
AU  - Simina Stefanescu
AU  - Spyridon Gkalpakiotis
AU  - Paul-Gunther Sator
AU  - Julia-Tatjana Maul
AU  - Andrea Szegedi
AU  - Paula C. Luna
AU  - Lynda Spelman
AU  - Simone Rubant
AU  - Tshepiso Madihlaba
AU  - Hongwei Wang
AU  - Doug Ashley
AU  - Kim A. Papp
PY  - 2026
JO  - Dermatology and Therapy
DO  - 10.1007/s13555-026-01954-0
UR  - https://doi.org/10.1007/s13555-026-01954-0
ER  -

APA

Thaçi, D., Wiemers, F., Lynde, C. W., Ohtsuki, M., Bianchi, L., Fougerousse, A., Aranibar, F. J. G. D., Stefanescu, S., Gkalpakiotis, S., Sator, P., Maul, J., Szegedi, A., Luna, P. C., Spelman, L., Rubant, S., Madihlaba, T., Wang, H., Ashley, D., & Papp, K. A. (2026). Real-World Effectiveness of Risankizumab for Moderate-to-Severe Plaque Psoriasis by Sub-populations: Interim Analysis from VALUE at 37 Months. Dermatology and Therapy. https://doi.org/10.1007/s13555-026-01954-0

Source records

crossref · retrieved 2026-11-07T20:06:43.431Z